2024-09-16 - Analysis Report
## DHR Stock Analysis Report

**Company Overview:** DHR (Danaher Corporation) is a global science and technology company, operating in various industries including life sciences, diagnostics, dental, environmental, and applied solutions.

**Performance Analysis:**

1. **Return and Relative Performance:**
    * DHR's cumulative return is **136.17%**, significantly outperforming the S&P 500 (VOO) with a cumulative return of **88.73%**.
    * The current relative divergence is **47.44**, indicating DHR has outperformed the S&P 500 by **47.44%** compared to its historical performance. 
    * The relative divergence is at the **38.25%** percentile of its historical range, suggesting DHR has outperformed the S&P 500 in the past but not dramatically so.

2. **Recent Price Movement:**
    * Closing Price: **274.25**
    * 5-day moving average: **273.31**
    * 20-day moving average: **269.31**
    * 60-day moving average: **261.52**
    * The stock is trading above all its moving averages, indicating a positive price trend.

3. **Technical Indicators:**
    * RSI (Relative Strength Index): **58.3**
    * PPO (Percentage Price Oscillator): **0.15**
    * Delta_Previous_Relative_Divergence: **0.79**, indicating a potential short-term upward trend.
    * Expected Return: **76.6%**, suggesting a potential maximum 5-year return on investment.

4. **Recent Earnings and Outlook:**

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2024-07-23 | 1.23  | 5.74 B$    |
| 2024-04-23 | 1.47  | 5.80 B$    |
| 2024-02-21 | 1.46  | 6.41 B$    |
| 2023-10-24 | 1.53  | 5.62 B$    |
| 2024-02-21 | 1.53  | 5.62 B$    |

The most recent earnings report for the quarter ending July 23, 2024, showed EPS of **1.23** and revenue of **5.74 B$**. This slightly missed analysts' expectations for EPS of **1.32** and revenue of **5.80 B$**. 

**Overall Analysis:**

DHR's strong performance with consistently high returns and its outperformance against the S&P 500 indicate a robust company with a promising future. The recent earnings report, while slightly missing estimates, still shows a healthy revenue stream and growth potential. 

The technical indicators, including RSI and PPO, suggest a positive price trend and the upward trend indicated by Delta_Previous_Relative_Divergence reinforces this. The high Expected Return further supports the potential for long-term growth.

In conclusion, DHR appears to be a strong investment option with a history of exceeding expectations. The company's continued focus on innovation, its diverse portfolio, and its robust financial performance make it an attractive investment opportunity. 
